Cargando…
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype
INTRODUCTION: Esmirtazapine is evaluated as a novel drug for treatment of insomnia. PURPOSE: The present study was designed to assess residual effects of single and repeated doses of esmirtazapine 1.5 and 4.5 mg on actual driving in 32 healthy volunteers in a double-blind, placebo-controlled study....
Autores principales: | Ramaekers, Johannes G., Conen, Silke, de Kam, Pieter Jan, Braat, Sabine, Peeters, Pierre, Theunissen, Eef L., Ivgy-may, Neely |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083504/ https://www.ncbi.nlm.nih.gov/pubmed/21246188 http://dx.doi.org/10.1007/s00213-010-2149-4 |
Ejemplares similares
-
MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid
por: Bosker, Wendy M., et al.
Publicado: (2011) -
Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
por: Ramaekers, Johannes G., et al.
Publicado: (2022) -
A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022) -
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
por: Prevete, Elisabeth, et al.
Publicado: (2021) -
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
por: Ramaekers, Johannes G., et al.
Publicado: (2010)